Text Size

Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease – A randomised comparative study

Amrane M., Creuzot-Garcher C., Robert P.-Y., Ismail D., Garrigue J.-S., Pisella P.-J., Baudouin C.


  • 2014
  • Journal Francais d'Ophtalmologie
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Clinical development

  • Affiliations

    Santen SAS, 1, rue Pierre-Fontaine, Evry cedex, 91058, France; Service D'ophtalmologie, CHU de Dijon, 3, rue du Faubourg-Raines, Dijon, 21000, France; Service D'ophtalmologie, CHU Dupuytren, 2, avenue Martin-Luther-King, Limoges, 87000, France; Service D'ophtalmologie, CHU Bretonneau, 2, boulevard Tonnellé, Tours, 37000, France; Service D'ophtalmologie, Centre National D'ophtalmologie des Quinze-Vingts, Institut de la Vision, 28, rue de Charenton, Paris, 75012, France; Hôpital Ambroise-Paré, AP-HP, 9, avenue Charles-de-Gaulle, Boulogne-Billancourt, 92100, France; Université de Versailles Saint-Quentin-en-Yvelines, 55, avenue de Paris, Versailles, 78000, France

Related Publications

Trans-eyelid distribution of epinastine to the conjunctiva following eyelid application in rabbits

Mochizuki T.; Hata T.; Mori N.; Yamazaki T.; Noto T.; Mano H.


Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.


Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022